Nutrition and Health Strategy Consulting

Turning insight into the right health strategy

Food, ingredient, nutraceutical, and biotech companies face increasing pressure to innovate around health. However, not every consumer trend translates into a scientifically credible, regulatorily feasible, or commercially viable opportunity. Einerhand Science & Innovation provides nutrition and health strategy consulting to support early-stage decision-making, helping companies invest in the right health benefits, technologies, and markets with confidence.

From Consumer Insight to Science-Based Health Strategy

Companies often struggle to distinguish between real unmet health needs and short-lived trends. We support clients by translating consumer insights, market signals, and emerging health topics into science-driven nutrition and health strategies that are grounded in biological plausibility and current evidence.

Our work focuses on identifying which health benefits are:

Rather than trend spotting alone, we critically assess whether a perceived consumer need can be credibly addressed with food ingredients, supplements, or nutrition solutions. This approach helps avoid early investment in concepts that later prove impossible to substantiate or communicate compliantly.

Clients use this strategic input to define health platforms, prioritize innovation focus areas, and align internal stakeholders around a shared, evidence-based direction.

Strategic Decision Support for Innovation, Due Diligence, and Investment

A core part of our nutrition and health strategy work is early-stage strategic decision support. We frequently assist food companies, ingredient suppliers, start-ups, and investors with questions such as whether to invest in a specific technology, ingredient, or company, and what the associated scientific and regulatory risks are.

Typical projects include:

These projects combine scientific assessment with market and regulatory analysis, often resulting in clear go / no-go recommendations, prioritisation scenarios, and strategic positioning guidance. This allows clients to make informed innovation or investment decisions before committing significant resources.

Aligning Science, Regulation, and Commercial Ambition

Misalignment between scientific reality, regulatory constraints, and marketing ambition is a common cause of failed innovation. Einerhand Science & Innovation helps bridge this gap by ensuring that early health strategies are feasible, defensible, and aligned across functions.

We work at the interface of:

By addressing these dimensions simultaneously, we help clients avoid “science wash”, reduce compliance risk, and build strategies that can evolve into substantiated, claimable health benefits over time. This alignment is particularly critical in sensitive categories such as infant nutrition, medical nutrition, gut health, immunity, and healthy ageing.

Scientific Advisory Board (SAB) Support for Start-ups and Scale-ups among other

In addition to project-based strategy support, Sandra Einerhand regularly serves as an independent scientific advisor on Scientific Advisory Boards (SABs), particularly for start-ups and scale-ups in food, nutrition, and biotechnology.

In addition to project-based strategy support, Einerhand Science & Innovation regularly serves as an independent scientific advisor on Scientific Advisory Boards (SABs), particularly for start-ups and scale-ups in food, nutrition, and biotechnology.

In this role, we support companies not only on scientific and regulatory decision-making, but also on making innovation commercially attractive. Drawing on experience across academia, B2B ingredient businesses, and B2C product companies, we help translate scientific innovation into propositions that resonate with investors, partners, and customers.

This includes advising on health benefit positioning, substantiation pathways, portfolio focus, and strategic storytelling, while ensuring that scientific integrity and regulatory feasibility are maintained. Our broad network across science, industry, and innovation ecosystems further supports companies in building credibility and traction at an early stage.

This type of scientific advisory support is particularly valuable for early-stage companies developing novel ingredients, infant nutrition products, or medical nutrition solutions.

See our Nutrition and Health Strategy project cases for examples of how this approach is applied in practice.

What Clients Gain

Typical Deliverables

Frequently Asked Questions (FAQ)

Nutrition and health strategy consulting helps companies define which health benefits to pursue based on scientific evidence, consumer relevance, and regulatory feasibility. It supports early innovation, portfolio decisions, and investment choices.

Nutrition and health strategy focuses on direction-setting before development. It answers what to pursue and why, rather than how to formulate or test a product.

Yes. We regularly support food companies, start-ups, and investors by assessing scientific credibility, regulatory risks, market potential, and competitive positioning as part of due diligence processes.

We work with food, ingredient, nutraceutical, infant-, medical nutrition, and biotech companies, with strong expertise in early life nutrition, gut and mental health, healthy ageing, biotics, lipids, plant proteins and (alternative)dairy.

Absolutely. Evaluating biological plausibility and evidence strength behind emerging health trends is a core part of our nutrition and health strategy work.